5 Pharmaceuticals for the treatment of neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; drug delivery agents in the form of capsules, granules, liquids, transdermal systems(patches), pellets, pills, powders, solutions, suspensions or tablets that facilitate the delivery of pharmaceutical preparations; medicated skin care preparations